Bristol-Myers Squibb Co. (BMY)

Common Stock Valuation Ratios (Price Multiples) Quarterly Data

Difficulty: Beginner

Valuation ratios measure the quantity of an asset or flaw (e.g., earnings) associated with ownership of a specified claim (e.g., a share of ownership of the enterprise).

Historical Valuation Ratios (Summary)

Bristol-Myers Squibb Co., historical price multiples (quarterly data)

		Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
	Price to earnings (P/E)
	Price to operating profit (P/OP)
	Price to sales (P/S)
	Price to book value (P/BV)

Ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	Bristol-Myers Squibb Co.'s P/E ratio increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	Bristol-Myers Squibb Co.'s P/OP ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	Bristol-Myers Squibb Co.'s P/S ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company's required rate of return and its actual rate of return.	Bristol-Myers Squibb Co.'s P/BV ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top

Price to Earnings (P/E)

Bristol-Myers Squibb Co., historical P/E calculation (quarterly data)

		Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
	No. shares of common stock outstanding¹
	Selected Financial Data (USD $)
	Net earnings (loss) attributable to BMS (in millions)
	Earnings per share (EPS)³
	Share price^1, 2

	P/E ratio⁴

¹ Data adjusted for splits and stock dividends.

² Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

³ EPS = (Net earnings (loss) attributable to BMS_{Q1 2018} + Net earnings (loss) attributable to BMS_{Q4 2017} + Net earnings (loss) attributable to BMS_{Q3 2017} + Net earnings (loss) attributable to BMS_{Q2 2017}) ÷ No. shares of common stock outstanding
= ( + + + ) ÷ =

⁴ P/E ratio = Share price ÷ EPS
= ÷ =

Ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	Bristol-Myers Squibb Co.'s P/E ratio increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.

Top

Price to Operating Profit (P/OP)

Bristol-Myers Squibb Co., historical P/OP calculation (quarterly data)

		Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
	No. shares of common stock outstanding¹
	Selected Financial Data (USD $)
	Operating income (in millions)
	Operating profit per share³
	Share price^1, 2

	P/OP ratio⁴

¹ Data adjusted for splits and stock dividends.

² Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

³ Operating profit per share = (Operating income_{Q1 2018} + Operating income_{Q4 2017} + Operating income_{Q3 2017} + Operating income_{Q2 2017}) ÷ No. shares of common stock outstanding
= ( + + + ) ÷ =

⁴ P/OP ratio = Share price ÷ Operating profit per share
= ÷ =

Ratio	Description	The company
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	Bristol-Myers Squibb Co.'s P/OP ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top

Price to Sales (P/S)

Bristol-Myers Squibb Co., historical P/S calculation (quarterly data)

		Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
	No. shares of common stock outstanding¹
	Selected Financial Data (USD $)
	Revenues (in millions)
	Sales per share³
	Share price^1, 2

	P/S ratio⁴

¹ Data adjusted for splits and stock dividends.

² Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

³ Sales per share = (Revenues_{Q1 2018} + Revenues_{Q4 2017} + Revenues_{Q3 2017} + Revenues_{Q2 2017}) ÷ No. shares of common stock outstanding
= ( + + + ) ÷ =

⁴ P/S ratio = Share price ÷ Sales per share
= ÷ =

Ratio	Description	The company
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	Bristol-Myers Squibb Co.'s P/S ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top

Price to Book Value (P/BV)

Bristol-Myers Squibb Co., historical P/BV calculation (quarterly data)

		Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
	No. shares of common stock outstanding¹
	Selected Financial Data (USD $)
	Total Bristol-Myers Squibb Company shareholders' equity (in millions)
	Book value per share (BVPS)³
	Share price^1, 2

	P/BV ratio⁴

¹ Data adjusted for splits and stock dividends.

² Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

³ BVPS = Total Bristol-Myers Squibb Company shareholders' equity ÷ No. shares of common stock outstanding
= ÷ =

⁴ P/BV ratio = Share price ÷ BVPS
= ÷ =

Ratio	Description	The company
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company's required rate of return and its actual rate of return.	Bristol-Myers Squibb Co.'s P/BV ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top

	Bristol-Myers Squibb Co.	Other companies (not purchased previously)
Long-term Trends
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Analysis
Financial Reporting Quality

	All companies
Long-term Trends
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Analysis
Financial Reporting Quality